The protective role of CD38 loss of function against oxidative injury and endothelial dysfunction in coronary ischemia/reperfusion was further demonstrated by the pharmacologic administration of potent CD38 inhibitor in additional experiments (Boslett et al., 2019). The gene discussed is CD38; the disease is endothelial dysfunction.